Donor Site Morbidity and Buccinator Muscle Integrity After Buccinator Myomucosal Flap Surgery in Patients With Velopharyngeal Incompetence

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSohag University

About this trial

The aim of this study is to evaluate donor site morbidity and buccinator muscle integrity following the use of buccinator myomucosa flap in patients with velopharyngeal incompetence.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients diagnosed with velopharyngeal incompetence undergoing palatal lengthening using bilateral posteriorly based buccinator myomucosal flaps.

Non-syndromic patients.

Disqualifiers

Syndromic cleft patients with associated neuromuscular disorders.

History of previous cheek surgery affecting the buccinator muscle.

Patients who declined participation in the study.

Trial population

This study is a prospective comparative and retrospective study designed to evaluate the donor site morbidity and buccinator muscle integrity after buccinator myomucosal flap in patients with velopharyngeal incompetence

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Bilateral posteriorly based buccinator myomucosal flap surgery

    Procedure/Surgery

    Palatal lengthening will be performed using bilateral posteriorly based buccinator myomucosal flaps in patients with velopharyngeal incompetence.

Treatment groups

15 Participants
are divided into 1 treatment group
Group A: Buccinator Myomucosal Flap Group1 intervention

Trial outcomes

Primary outcomes

1

Buccinator muscle functional integrity

Buccinator function will be assessed by the 10-second cheek puff test to retain air for 10 seconds. The examiner will record whether the participant completes the test and whether air leakage or facial asymmetry is observed.

Time frame
3 months after surgery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.